Search Results - "Hernáez, Tania"
-
1
SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?
Published in Transplantation (01-07-2022)“…Since the declaration of a new variant of concern (VOC), Omicron, by the World Health Organization in November 2021, a quick spread has been documented…”
Get full text
Journal Article -
2
Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals
Published in Gastroenterología y hepatología (01-10-2019)“…Eradication of the hepatitis C virus (HCV) with interferon-free therapies (DAAs) has modified the course of the disease, as the rate of patients with…”
Get more information
Journal Article -
3
Antioxidants Threaten Multikinase Inhibitor Efficacy against Liver Cancer by Blocking Mitochondrial Reactive Oxygen Species
Published in Antioxidants (24-08-2021)“…Sorafenib and regorafenib, multikinase inhibitors (MKIs) used as standard chemotherapeutic agents for hepatocellular carcinoma (HCC), generate reactive oxygen…”
Get full text
Journal Article -
4
SARS-CoV-2 and Liver Transplant: How Has It Behaved in This Sixth Wave?
Published in Transplantation (08-04-2022)Get full text
Journal Article -
5
Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances
Published in Cancers (26-01-2022)“…Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to be a serious medical problem with poor prognosis, without major therapeutic…”
Get full text
Journal Article -
6
Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models
Published in Cancers (01-02-2020)“…The multikinase inhibitor regorafenib, approved as second-line treatment for hepatocellular carcinoma (HCC) after sorafenib failure, may induce mitochondrial…”
Get full text
Journal Article -
7
-
8
THU-155 Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
9
Risk of recurrence of hepatocellular carcinoma in patients treated with interferon-free antivirals
Published in Gastroenterología y Hepatología (English Edition) (01-10-2019)“…Eradication of the hepatitis C virus with interferon-free therapies (DAAs) has modified the course of the disease, as the rate of patients with compensated…”
Get full text
Journal Article -
10
International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis
Published in Liver international (01-06-2020)“…Background & Aims Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to…”
Get full text
Journal Article -
11
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Published in Gastroenterología y Hepatología (English Edition) (01-10-2023)“…There is uncertainty regarding Wilson's disease (WD) management. To assess, in a multicenter Spanish retrospective cohort study, whether the approach to WD is…”
Get full text
Journal Article -
12